KESKO B/ FI0009000202 /
15/05/2024 8:10:20 | Diferencia +0.120 | Volumen | Bid12:45:24 | Ask12:45:24 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
16.635EUR | +0.73% | 0 Volumen de negocios: 0.000 |
16.655Volumen de oferta: 307 | 16.690Tamaño/ Volumen/ Formato de Ask: 306 | 6.7 mil millonesEUR | 6.11% | 13.35 |
GlobeNewswire
13:01
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presente...
GlobeNewswire
13:00
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
GlobeNewswire
13:00
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
GlobeNewswire
13:00
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
13:00
Boralex announces a substantial 62% increase in net earnings and continued disciplined development o...
GlobeNewswire
13:00
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
13:00
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the ...
GlobeNewswire
13:00
Creative Realities Inc. plans its expansion into EMEA and announces its beta launch to EMEA Integrat...
GlobeNewswire
13:00
Data Storage Corporation Reports 20% Increase in Revenue and Again Achieves Profitability for the 20...
GlobeNewswire
13:00
Penske Truck Leasing to Offer REE Automotive’s P7-C EV Trucks to its Customers for Demos and Orders ...
GlobeNewswire
13:00
Zapata AI Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:00
Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to C...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página